Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             69 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 360 A case series of thrombotic and thromboembolic complications of central venous access in cystic fibrosis patients Kandamany, N.
2012
11 Supplement 1 p. S149-
1 p.
artikel
2 322 Advances in transition: multi-level factors associated with adult achievement Barto, T.L.
2012
11 Supplement 1 p. S139-
1 p.
artikel
3 A fat lot of good: Balance and trends in fat intake in children with cystic fibrosis Smith, C.
2012
11 Supplement 1 p. 154-157
4 p.
artikel
4 A novel neutrophil derived inflammatory biomarker of pulmonary exacerbation in cystic fibrosis Reeves, Emer P.
2012
11 Supplement 1 p. 100-107
8 p.
artikel
5 6 A novel StripAssay for the detection of cystic fibrosis mutations in the Turkish population Puehringer, H.
2012
11 Supplement 1 p. S56-
1 p.
artikel
6 242 Are we missing salt depletion in cystic fibrosis? Sharp, S.
2012
11 Supplement 1 p. S118-
1 p.
artikel
7 Australian epidemic strain pseudomonas (AES-1) declines further in a cohort segregated cystic fibrosis clinic Griffiths, Amanda L.
2012
11 Supplement 1 p. 49-52
4 p.
artikel
8 47 Bronchitol (inhaled dry powder mannitol) in adult patients with cystic fibrosis Aitken, M.
2012
11 Supplement 1 p. S68-
1 p.
artikel
9 274 CF experience for respiratory trainees in the UK Nazareth, D.
2012
11 Supplement 1 p. S127-
1 p.
artikel
10 288 CF patients with totally implantable venous access devices (TIVAD): prospective survey of Doppler-US (DUS) central venous thrombosis (CVT) and thrombophilia (TB) assessment Munck, A.
2012
11 Supplement 1 p. S130-
1 p.
artikel
11 166 CF sputum rheology and the role of the airway mucin MUC5AC Horsley, A.
2012
11 Supplement 1 p. S99-
1 p.
artikel
12 Clinical evidence that V456A is a Cystic Fibrosis causing mutation in South Asians Uppaluri, L.
2012
11 Supplement 1 p. 312-315
4 p.
artikel
13 305 Comparison of contacts to adult and paediatric cystic fibrosis Clinical Nurse Specialists Butler, M.
2012
11 Supplement 1 p. S135-
1 p.
artikel
14 214 Core competencies for physiotherapists working with cystic fibrosis patients in Italy Tartali, C.
2012
11 Supplement 1 p. S111-
1 p.
artikel
15 20 Cystic fibrosis newborn screening in Italy: survey for assessment of technical-scientific and organizational issues Repetto, T.
2012
11 Supplement 1 p. S60-
1 p.
artikel
16 Cystic fibrosis research in allied health and nursing professions Bradley, Judy M.
2012
11 Supplement 1 p. 387-392
6 p.
artikel
17 Diabetes mellitus and survival in cystic fibrosis patients after lung transplantation Hofer, Markus
2012
11 Supplement 1 p. 131-136
6 p.
artikel
18 319 Do symptoms of depression determine the course of lung function in patients with cystic fibrosis? Fidika, A.
2012
11 Supplement 1 p. S138-
1 p.
artikel
19 111 Epidemiology and species distribution of Burkholderia cepacia complex in Ireland. A 10 year review Collins, J.
2012
11 Supplement 1 p. S84-
1 p.
artikel
20 239 Establishment of an F508del pseudoislet model for the study of CF-related diabetes McClenaghan, N.H.
2012
11 Supplement 1 p. S117-
1 p.
artikel
21 152 Estrogen-regulated MicroRNAs control the expression of secretory leukoprotease inhibitor in monocytes McKiernan, P.
2012
11 Supplement 1 p. S95-
1 p.
artikel
22 197 Evaluation of aerobic exercise capacity and daily functioning of patients with cystic fibrosis Eisenstadt, I.
2012
11 Supplement 1 p. S107-
1 p.
artikel
23 270 Factors associated with vitamin K deficiency in adults with cystic fibrosis Ochota, A.
2012
11 Supplement 1 p. S125-
1 p.
artikel
24 108 First identification of non-lactose fermenting Gram negative respiratory isolates from an Irish cystic fibrosis population using matrix-assisted laser desorption ionisation-time of flight mass spectrometry (MALDI-TOF MS) Prior, A.-R.
2012
11 Supplement 1 p. S84-
1 p.
artikel
25 149 Gibberellin induces the NF-úB inhibitor A20 in airway epithelial cells Schock, B.C.
2012
11 Supplement 1 p. S94-
1 p.
artikel
26 33 Hypoxia reduces internalization of Pseudomonas aeruginosa in pulmonary epithelial cells Schaible, B.
2012
11 Supplement 1 p. S64-
1 p.
artikel
27 IL-17A as a regulator of neutrophil survival in nasal polyp disease of patients with and without cystic fibrosis Derycke, L.
2012
11 Supplement 1 p. 193-200
8 p.
artikel
28 Immunomodulatory activity of vardenafil on induced lung inflammation in cystic fibrosis mice Lubamba, Bob
2012
11 Supplement 1 p. 266-273
8 p.
artikel
29 183 Impact of progression of cystic fibrosis lung disease on quality of life Tepper, L.A.
2012
11 Supplement 1 p. S103-
1 p.
artikel
30 80 Investigation of the potential mechanisms of antibiotic resistance in the cystic fibrosis pathogen, Burkholderia cepacia complex Kennedy, S.
2012
11 Supplement 1 p. S77-
1 p.
artikel
31 135 Is the lung of cystic fibrosis patients a reservoir of extended-spectrum beta-lactamase-producing Enterobacteriaceae? Fiscarelli, E.
2012
11 Supplement 1 p. S90-
1 p.
artikel
32 200 Long inhalation time is associated with short treatment time when using the I-neb AAD System in target inhalation mode Spencer, T.
2012
11 Supplement 1 p. S107-
1 p.
artikel
33 Multiple antibiotic-resistant Pseudomonas aeruginosa and lung function decline in patients with cystic fibrosis Ren, Clement L.
2012
11 Supplement 1 p. 293-299
7 p.
artikel
34 58 No antibiotic cross-resistance after 1 year of continuous aztreonam for inhalation solution (AZLI) in cystic fibrosis (CF) patients (pts) with chronic Burkholderia (BURK) infection Burns, J.
2012
11 Supplement 1 p. S71-
1 p.
artikel
35 PCR detection of Burkholderia cepacia complex as one of key factors to handle a long-term outbreak Dedeckova, Klara
2012
11 Supplement 1 p. 440-445
6 p.
artikel
36 125 Presence of Pandoraea and Herbaspirillum species within the Irish CF population Collins, J.
2012
11 Supplement 1 p. S88-
1 p.
artikel
37 229 Prucalopride: a review of the first 12 months of use Williams, K.
2012
11 Supplement 1 p. S115-
1 p.
artikel
38 Qualitative analysis of parent experiences with achieving cystic fibrosis nutrition recommendations Filigno, Stephanie S.
2012
11 Supplement 1 p. 125-130
6 p.
artikel
39 Reduced levels of active GLP-1 in patients with cystic fibrosis with and without diabetes mellitus Hillman, Magnus
2012
11 Supplement 1 p. 144-149
6 p.
artikel
40 77 Risk factor of multi-drug resistant Pseudomonas aeruginosa (MDR-PA) emergence in cystic fibrosis patients Patout, M.
2012
11 Supplement 1 p. S76-
1 p.
artikel
41 Sinonasal persistence of Pseudomonas aeruginosa after lung transplantation Mainz, J.G.
2012
11 Supplement 1 p. 158-161
4 p.
artikel
42 Smoking prevention and cessation programme in cystic fibrosis: Integrating an environmental health approach Ortega-García, Juan Antonio
2012
11 Supplement 1 p. 34-39
6 p.
artikel
43 94 Statins, a widely used cholesterol-lowering drug, modulate key virulence behaviour of Pseudomonas aeruginosa Hennessy, E.
2012
11 Supplement 1 p. S80-
1 p.
artikel
44 23 Sweat testing in a tertiary clinic – reasons, results and methodology Mense, L.
2012
11 Supplement 1 p. S61-
1 p.
artikel
45 332 The prevalence of eating disordered attitudes and behaviour in the cystic fibrosis lung transplant population Mohan, K.
2012
11 Supplement 1 p. S141-
1 p.
artikel
46 346 The prevalence of F508del and its relation to clinical manifestation in CF patients from Albania Vevecka, E.
2012
11 Supplement 1 p. S145-
1 p.
artikel
47 1 The role of CFTR genetic testing in diagnosis of cystic fibrosis Fustik, S.
2012
11 Supplement 1 p. S55-
1 p.
artikel
48 256 The use of high energy milk formula for alimentary status correction in children with cystic fibrosis (CF) Roslavtseva, E.
2012
11 Supplement 1 p. S122-
1 p.
artikel
49 63 Time to recurrence and antimicrobial susceptibility of first-time detected Achromobacter xylosoxidans in respiratory tract specimens from patients with cystic fibrosis Wang, M.
2012
11 Supplement 1 p. S72-
1 p.
artikel
50 Towards an individualized protocol for workload increments in cardiopulmonary exercise testing in children and adolescents with cystic fibrosis Hulzebos, H.J.
2012
11 Supplement 1 p. 550-554
5 p.
artikel
51 WS16.5 Airway clearance therapy and exercise in cystic fibrosis: patients’ perceptions versus participation Kennedy, F.
2012
11 Supplement 1 p. S36-
1 p.
artikel
52 WS5.5 A randomised, open label phase 3 study to evaluate the efficacy and safety of a dry powder formulation of inhaled colistimethate sodium (Colobreathe®) versus tobramycin nebuliser solution (TNS) in cystic fibrosis subjects with chronic Pseudomonas aeruginosa lung infection Goldman, M.
2012
11 Supplement 1 p. S12-
1 p.
artikel
53 WS9.5 CF epithelial cells are a source of pulmonary cathepsin S via increased IRF-1 Weldon, S.
2012
11 Supplement 1 p. S20-
1 p.
artikel
54 WS8.6 Decision algorithm and scoring method for the classification of variants of unknown clinical significance in the CFTR gene Raynal, C.
2012
11 Supplement 1 p. S17-
1 p.
artikel
55 WS11.6 Environmental Burkholderia cenocepacia strains can disrupt epithelial integrity in bronchial epithelial cells in vitro and have a more profound effect on ZO-1 in CF cells Bevivino, A.
2012
11 Supplement 1 p. S25-
1 p.
artikel
56 WS10.1 Evaluation of musculoskeletal and postural function in cystic fibrosis using a physiotherapy screening tool Button, B.M.
2012
11 Supplement 1 p. S22-
1 p.
artikel
57 WS23.4 High Rhinovirus burden in lower airways of children with cystic fibrosis Kieninger, E.
2012
11 Supplement 1 p. S51-
1 p.
artikel
58 WS17.8 Inhibition of leukotriene B4 signaling by alpha-1 antitrypsin: support for the use of aerosolized alpha-1 antitrypsin therapy in cystic fibrosis O'Dwyer, C.A.
2012
11 Supplement 1 p. S39-
1 p.
artikel
59 WS2.1 Investigation of MiRNA regulation of ER stress in cystic fibrosis airway epithelium Oglesby, I.K.
2012
11 Supplement 1 p. S3-
1 p.
artikel
60 WS10.4 Length of hospital stay and changed weekend physiotherapy cystic fibrosis service Moran, F.C.
2012
11 Supplement 1 p. S22-
1 p.
artikel
61 WS6.3 Measures of nutritional status in two Phase 3 trials of ivacaftor in subjects with cystic fibrosis who have the G551D-CFTR mutation Borowitz, D.
2012
11 Supplement 1 p. S13-
1 p.
artikel
62 WS17.1 Modulation of inflammatory mediators associated with cystic fibrosis by alpha-1 antitrypsin Bergin, D.A.
2012
11 Supplement 1 p. S38-
1 p.
artikel
63 WS12.2 Outcomes of patients with cystic fibrosis admitted to an intensive care unit Markewitz, B.
2012
11 Supplement 1 p. S27-
1 p.
artikel
64 WS18.2 Persistent elevation of antibodies against Pseudomonas aeruginosa following successful eradication? Kappler, M.
2012
11 Supplement 1 p. S41-
1 p.
artikel
65 WS23.1 Progression of lung disease within specific genotypes of patients with cystic fibrosis (CF) – Which lung function parameter differentiates best? Gallati, S.
2012
11 Supplement 1 p. S51-
1 p.
artikel
66 WS20.4 Real-time PCR (RT-PCR) provides a “window of opportunity”: optimal screening of patients with cystic fibrosis (CF) through an earlier detection of Pseudomonas aeruginosa (PA) Hérv-Arnaud, G.
2012
11 Supplement 1 p. S45-
1 p.
artikel
67 WS17.9 The B lymphocyte differentiation factor, BAFF, is expressed in the lung of cystic fibrosis patients and in a mouse model of Pseudomonas aeruginosa infection Saint, G.
2012
11 Supplement 1 p. S40-
1 p.
artikel
68 WS3.6 The CF-ABLE score: a novel clinical prediction tool in cystic fibrosis McCarthy, C.
2012
11 Supplement 1 p. S7-
1 p.
artikel
69 WS1.6 The need of an appropriate diagnosis of gastroesophageal reflux disease in cystic fibrosis patients: impact on clinical management Alghisi, F.
2012
11 Supplement 1 p. S2-
1 p.
artikel
                             69 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland